Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety and Efficacy of a Novel Malathion Formulation in the Treatment of Head Lice
This study has been completed.
Study NCT00244439   Information provided by Taro Pharmaceuticals USA
First Received: October 24, 2005   Last Updated: May 4, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Lice Infestations
More general conditions related to this trial
Ectoparasitic Infestations
Parasitic Diseases
Skin Diseases
Skin Diseases, Infectious
Skin Diseases, Parasitic
Interventions listed in this trial
MALG
Ovide (malathion) lotion 0.05%
Permethrin 1%
Additional drug interventions recognized in this trial
Malathion
Permethrin
More general drug interventions related to this trial
Cholinergic Agents
Cholinesterase Inhibitors
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Taro Pharmaceuticals USA


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services